Camson Bio Peer Comparison

BSE: 538858

₹3.31

₹-0.06 (-1.78%)

As on 11-May-2020IST

Market cap

₹10 Cr

Revenue (TTM)

₹5 Cr

P/E Ratio

--

P/B Ratio

0.3

Div. Yield

0 %

Edit

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Market cap (₹ Cr)	10	20,203	16,360	6,541	3,987
Revenue (₹ Cr)	5	3,245	5,595	5,357	2,962
Net Profit (₹ Cr)	-25.18	579.39	732.10	626.21	214.00
Net Margin (%)	-193.02	17.04	12.71	11.46	7.12
RoE (%)	--	17.35	24.05	21.55	13.45
Price to Earnings	--	34.87	22.35	10.45	18.63
Price-To-Book	0.27	5.61	4.98	2.03	1.84

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (₹ Cr)

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Operating Revenue	4.98	2,228.42	3,167.30	1,997.56	1,983.96
Total Income	8.18	2,235.98	3,220.70	2,018.18	2,014.61
Total Expenditure	21.37	1,937.66	2,686.50	1,663.54	1,740.21
EBITDA	-16.39	290.76	480.80	334.02	243.75
Depreciation	6.97	27.80	43.80	99.39	46.08
EBIT	-23.36	262.96	437.00	234.62	197.68
Interest	1.14	3.72	10.40	20.22	8.06
Other Income	3.20	7.56	53.40	20.62	30.65
Exceptional Items	--	-6.96	--	--	--
Profit before Tax	-21.31	259.84	480.00	235.03	220.26
Provision for Tax	0.59	94.05	142.90	58.68	65.48
Profit after Tax	-21.90	165.80	337.10	176.34	154.78

Liabilities (₹ Cr)

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Shareholder's Funds	44.75	1,048.40	2,239.40	1,283.91	1,285.93
Minority Interest	--	--	--	0.24	1.84
Non-Current Liabilities	12.21	30.23	1,614.20	403.94	60.64
Current Liabilities	63.97	781.34	1,683.80	821.65	814.20
Total Liabilities	122.11	1,859.97	5,546.30	2,509.74	2,162.61

Assets (₹ Cr)

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Non-Current Assets	85.97	318.28	2,261.70	961.56	749.41
Current Assets	34.96	1,541.69	3,271.40	1,548.18	1,413.20
Total Assets	122.11	1,859.97	5,546.30	2,509.74	2,162.61
Total Debt*	49.83	19.75	0.00	0.09	72.84
Net Current Assets	-29.01	760.35	1,587.60	726.53	598.99
Contingent Liabilities	20.41	25.91	676.50	55.38	149.85

Cashflow (₹ Cr)

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Cash From Operating Activities	0.00	77.76	432.80	556.14	80.06
Cash Flow from Investing Activities	-0.01	-35.40	-414.70	-359.83	-51.45
Cash from Financing Activities	-0.02	-65.45	-158.30	-215.36	-51.50
Net Cash Inflow / Outflow	-0.03	-23.08	-140.20	-19.06	-22.89

Ratios

Profitability Ratios

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
ROCE (%)	-19.21	25.94	24.41	19.72	17.74
ROE (%)	-39.31	21.35	16.83	14.58	12.50
ROA (%)	-16.76	9.42	6.90	7.00	7.48
EBIT Margin (%)	-265.07	13.39	16.87	17.75	13.83
Net Margin (%)	-267.80	7.41	10.47	8.74	7.68
Cash Profit Margin (%)	-299.89	7.72	10.85	13.80	7.66

Growth Ratios

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Revenue Growth (%)	-74.23	16.50	16.88	17.05	10.78
EBIT Growth (%)	-1,090.48	19.29	19.19	-4.77	-1.98
Net Profit Growth (%)	-95.20	14.25	12.33	-7.56	-7.32
EPS Growth (%)	-95.20	14.25	12.33	-7.56	-7.30
Book Value Growth (%)	-32.88	12.94	25.33	13.14	8.01

Valuation Ratios

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Price / Earnings	0.00	0.00	44.61	19.05	20.66
Price / Book Value	0.46	0.00	6.75	2.62	2.50
Dividend Yield (%)	0.00	--	0.41	1.07	1.51
EV/EBITDA	-5.35	0.81	27.06	9.12	11.80
Market Cap (₹ Cr)	20.76	0.00	15,038.49	3,359.36	3,210.68

Solvency Ratios

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Debt to Equity	1.11	0.02	0.00	0.00	0.06
Short term debt to equity ratio	0.86	0.02	--	0.15	0.04
Current Ratio	0.55	1.97	1.94	1.88	1.74
Quick Ratio	0.14	1.10	1.26	1.45	0.91
Interest Coverage	-17.64	70.93	47.15	12.62	28.32

Operating Efficiency Ratios

	Camson Bio	Sumitomo Chemical	Bayer Cropscience	Sharda Cropchem	Rallis India
Debtors to sales (%)	132.08	30.11	22.06	40.62	22.64
Asset Turnover	0.04	1.43	0.72	0.79	1.27
Receivable days	428.55	89.00	70.58	155.62	59.07
Inventory Days	2,429.07	93.88	98.63	81.80	86.70
Payable days	191.24	142.73	107.39	167.07	176.44
Cash Conversion Cycle	2,666.37	40.15	61.82	70.34	-30.67

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.